Sexually Transmitted Diseases (STDs) Drug Market Current Trends and Future Aspect Analysis 2017 - 2025
The rising prevalence of sexually transmitted diseases has upped the demand for effective drugs. To capitalize on the prevailing trend, a majority of the market players are focusing on research and development activities. Favorable government policies and recent initiatives have further provided boost to their plans of expanding product portfolio, finds Transparency Market Research (TMR) in a new study. According to the report, companies such as Bayer Healthcare, Hoffmann La Roche, Pfizer INC, Bristol-Myers Squibb Co., Gilead Sciences, AbbVie, Inc.,...
View full press release